01:56 PM EDT, 04/02/2024 (MT Newswires) -- Acorda Therapeutics ( ACOR ) slumped past 76% on Tuesday trading, a day after it signed an agreement to sell substantially all its assets to Merz Therapeutics for $185 million.

Intraday trading volume was over 3.3 million versus a daily average of about 4,000.

Gritstone Bio ( GRTS ) said late Monday it priced an offering of about 8.3 million common shares and accompanying warrants to purchase up to about 8.3 million common shares at a combined price of $1.50 per share and accompanying warrant.

Shares sank 50% as intraday trading volume soared to more than 18 million from a daily average of about 2.16 million.

Verve Therapeutics ( VERV ) shares slumped after the company paused enrollment in its Heart-1 clinical trial after observing "laboratory abnormalities" in one participant.

Shares dropped 37%, with intraday trading volume at over 7.2 million compared with a daily average of about 1.08 million.

Price: 3.13, Change: -10.19, Percent Change: -76.50